Try our Advanced Search for more refined results

September 07, 2017

DEPOMED, INC. v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al

Track this case

Case Number:

3:17-cv-06866

Court:

New Jersey

Nature of Suit:

Contract: Other

Judge:

Michael A. Shipp

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 31, 2017

    Valeant Pays $13M To End Diabetes Drug Royalty Claims

    Valeant Pharmaceuticals International Inc. will pay $13 million to biotechnology company PDL BioPharma Inc. to settle a lawsuit alleging that Valeant owes more than $20 million in unpaid royalties for sales of diabetes drug Glumetza, PDL BioPharma said Monday.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login